[Economics of quality control in clinical laboratories]. 1997

P Shtern, and I Kratokhvila, and B Fridesku

UI MeSH Term Description Entries
D007753 Laboratories Facilities equipped to carry out investigative procedures. Laboratory
D011786 Quality Control A system for verifying and maintaining a desired level of quality in a product or process by careful planning, use of proper equipment, continued inspection, and corrective action as required. (Random House Unabridged Dictionary, 2d ed) Control, Quality,Controls, Quality,Quality Controls
D003365 Costs and Cost Analysis Absolute, comparative, or differential costs pertaining to services, institutions, resources, etc., or the analysis and study of these costs. Affordability,Analysis, Cost,Cost,Cost Analysis,Cost Comparison,Cost Measures,Cost-Minimization Analysis,Costs and Cost Analyses,Costs, Cost Analysis,Pricing,Affordabilities,Analyses, Cost,Analyses, Cost-Minimization,Analysis, Cost-Minimization,Comparison, Cost,Comparisons, Cost,Cost Analyses,Cost Comparisons,Cost Measure,Cost Minimization Analysis,Cost, Cost Analysis,Cost-Minimization Analyses,Costs,Measure, Cost,Measures, Cost
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D018153 Czech Republic Created 1 January 1993 as a result of the division of Czechoslovakia into the Czech Republic and Slovakia.

Related Publications

P Shtern, and I Kratokhvila, and B Fridesku
September 1959, Canadian journal of medical technology,
P Shtern, and I Kratokhvila, and B Fridesku
June 1971, Quaderni Sclavo di diagnostica clinica e di laboratorio,
P Shtern, and I Kratokhvila, and B Fridesku
April 1972, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
P Shtern, and I Kratokhvila, and B Fridesku
October 1963, Postgraduate medicine,
P Shtern, and I Kratokhvila, and B Fridesku
January 1995, Klinicheskaia laboratornaia diagnostika,
P Shtern, and I Kratokhvila, and B Fridesku
January 2000, Annales de biologie clinique,
P Shtern, and I Kratokhvila, and B Fridesku
March 1980, Annals of clinical biochemistry,
P Shtern, and I Kratokhvila, and B Fridesku
March 2014, Joint Commission perspectives. Joint Commission on Accreditation of Healthcare Organizations,
P Shtern, and I Kratokhvila, and B Fridesku
January 1971, Annali dell'Istituto superiore di sanita,
P Shtern, and I Kratokhvila, and B Fridesku
September 1992, Indian journal of medical sciences,
Copied contents to your clipboard!